REBECCA FREDRICH: Open Payments
NPI 1720490360 · WARSAW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 49 payments from 13 companies in 2025. Trend: 2023 $644 · 2024 $1,251 · 2025 $701
Food & beverage: $614Education: $87
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $228 |
| Lundbeck LLC | 16 | $156 |
| ABBVIE INC. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| UCB, Inc. | 2 | $35 |
| ARGENX US, INC. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| TG Therapeutics, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| LivaNova USA, Inc. | 1 | $17 |
Products named: AUSTEDO XR, REXULTI, VYEPTI, KESIMPTA, UBRELVY, Rystiggo, VYVGART HYTRULO, ACTHAR.
Industry payments across MO — which companies pay providers there.
